Chronic Obstructive Pulmonary Disease - McKnight's Long Term Care News

Chronic Obstructive Pulmonary Disease

Clinical briefs for Tuesday, June 15

CMS issues reprieve for 2,500 nursing homes yet to report COVID vaccination rates … Former CMS administrator says nursing homes will remain key test sites for COVID therapies, other treatments … Philips recalls CPAP machines over cancer concerns … Gene treatment could slow Alzheimer’s without targeting brain plaques, new study shows … Jury trial set for maker of Alzheimer’s drug Namenda; company allegedly kept generic off the market

FDA approves Anoro Ellipta

The U.S. Food and Drug Administration have approved GlaxoSmithKline’s Anoro™ Ellipta™, the company announced. The product is used to treat chronic obstructive pulmonary disease.

Next post in Products